q4 2023 earnings call transcript sa transcripts thu, feb. 01 see all news » latest headlines all analysis news virtual neurology investor event sa transcripts sat, nov. 02 roche holding ag (rhhby) virtual neurology investor event conference transcript sa transcripts sat, nov. 02 roche: ...
AnystatementsregardingearningspersharegrowthisnotaprofitforecastandshouldnotbeinterpretedtomeanthatRoche’searningsorearnings pershareforthisyearoranysubsequentperiodwillnecessarilymatchorexceedthehistoricalpublishedearningsorearningspershareofRoche. Formarketedproductsdiscussedinthispresentation,pleaseseefullprescribinginformati...
(excl.PRhoanrmapareve, Ronsaalperseve AHR erosion1 Fx 2023 business sales AHR1) CER=Constant Exchange Rates; 1AHR: Avastin, Herceptin, Rituxan/MabThera 9 Acceleration of our growth momentum in 2023 Q4 2023 growth impacted by base effect from Ronapreve sales in Japan in 2022 14% 12% 13%...